NDC Active Ingredient Infliximab

Active Ingredient Information

What is Infliximab?

A chimeric monoclonal antibody to TNF-ALPHA that is used in the treatment of RHEUMATOID ARTHRITIS; ANKYLOSING SPONDYLITIS; PSORIATIC ARTHRITIS and CROHN'S DISEASE.

What is the usage for Infliximab?

This medication is used to treat certain types of arthritis (rheumatoid arthritis, arthritis of the spine, psoriatic arthritis), certain bowel diseases (Crohn's disease, ulcerative colitis), and a certain severe skin disease (chronic plaque psoriasis). In these conditions, the body's defense system (immune system) attacks healthy tissues. Infliximab works by blocking the actions of a certain natural substance (tumor necrosis factor alpha) in the body. This helps to decrease swelling (inflammation) and weaken your immune system, which slows or stops the damage from the disease. This monograph is about the following infliximab products: infliximab, infliximab-abda, infliximab-axxq, and infliximab-dyyb.

How many products in the NDC database contain Infliximab?

The NDC database has 11 products with the active ingredient Infliximab. The following table lists all the products that have this active ingredient.

NDC Products with Infliximab

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Status
0006-4305Proprietary Name: Renflexis InfliximabInjection, Powder, Lyophilized, For SolutionIntravenousMerck Sharp & Dohme LlcACTIVE
0069-0809Proprietary Name: Inflectra Infliximab-dyybInjection, Powder, Lyophilized, For SolutionIntravenousPfizer Laboratories Div Pfizer IncACTIVE
55513-670Proprietary Name: Avsola Infliximab-axxqInjection, Powder, Lyophilized, For SolutionIntravenousAmgen IncACTIVE
57894-030Proprietary Name: Remicade InfliximabInjection, Powder, Lyophilized, For SolutionIntravenousJanssen Biotech, Inc.ACTIVE
57894-160Proprietary Name: Infliximab InfliximabInjection, Powder, Lyophilized, For SolutionIntravenousJanssen Biotech, Inc.ACTIVE
68225-072Proprietary Name: InfliximabInjection, Powder, Lyophilized, For SolutionPatheon Italia S.p.a.ACTIVE
68225-088Proprietary Name: Infliximab, License Holder UnspecifiedInjection, Powder, Lyophilized, For SolutionPatheon Italia S.p.a.ACTIVE
71124-0008Proprietary Name: InfliximabLiquidSamsung Biologics Co., Ltd.ACTIVE
72606-025Proprietary Name: Zymfentra Infliximab-dyybInjectionSubcutaneousCelltrion Usa Inc.ACTIVE
72606-047Proprietary Name: Zymfentra Infliximab-dyybInjectionSubcutaneousCelltrion Usa Inc.ACTIVE
78206-162Proprietary Name: Renflexis InfliximabInjection, Powder, Lyophilized, For SolutionIntravenousOrganon LlcACTIVE
<